Verrica Pharmaceuticals Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 06/08/2026 | Mar 2026Filed 06/08/2026 | Sep 2025Filed 14/11/2025 | Jun 2025Filed 06/08/2026 | Mar 2025Filed 06/08/2026 | Sep 2024Filed 14/11/2025 | Jun 2024Filed 14/11/2025 | Mar 2024Filed 14/11/2025 |
|---|---|---|---|---|---|---|---|---|
| $5.9 | $5 | $14 | $13 | $3.4 | −$1.8 | $5.2 | $3.8 | |
| −$13 | −$9.7 | −$0.3 | $0.2 | −$9.7 | −$23 | −$17 | −$20 | |
| −$0.62 | −$0.45 | −$0.03 | $0.02 | −$1.03 | −$4.88 | −$3.70 | −$0.44 | |
| 21 | 21 | 9.5 | 9.5 | 9.5 | 4.7 | 4.7 | 46 |
Trend